United States · FDA National Drug Code directory
PREGABALIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64980-416_ed8357e8-6f9d-4b09-b3f0-48417fe7f481
- Product NDC
- 64980-416
- Form
- CAPSULE
- Composition / generic term
- PREGABALIN
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190719
- Source listing expiry
- 20261231
Source-listed ingredients
- PREGABALIN — 225 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (64980-416-01) / 10 CAPSULE in 1 BLISTER PACK · 64980-416-01
- 90 CAPSULE in 1 BOTTLE (64980-416-09) · 64980-416-09
- 1000 CAPSULE in 1 BOTTLE (64980-416-10) · 64980-416-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →